Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Neuropharmacology ; 39(3): 471-81, 2000 Jan 28.
Article in English | MEDLINE | ID: mdl-10698013

ABSTRACT

The present experiments investigated the effects of agents acting at serotonin (5-HT)-2 receptors on the performance of rats in a choice serial reaction time (5-CSRT) task in order to examine the role of 5-HT2 receptors in the modulation of attention and response control. The results indicate that DOI, [(+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride; 0.05, 0.1 and 0.2 mg/kg, subcutaneously], a 5-HT(2A/2C) agonist, slightly impaired the choice accuracy of the well performing rats and markedly increased their premature responding. DOI (0.05 and 0.1 mg/kg) had no effect on the latency to collect earned food pellets or to respond correctly, indicating that these lower doses of DOI did not reduce motivation for the food reward in this task. The selective effect of a low dose of DOI (0.1 mg/kg) on premature responding was completely blocked by ketanserin (0.2 mg/kg), a 5-HT2A antagonist, and ritanserin (0.3 mg/kg), a 5-HT(2A/2C) antagonist, but only partially blocked by a high dose of SER082 (1.0 mg/kg), a 5-HT2C antagonist. In contrast to DOI, mCPP, [1-(3-phenyl)piperazine; 0.05 and 0.15 mg/kg], a 5-HT2C agonist, had no effect on choice accuracy or premature responding, but it reduced behavioral activity and/or arousal as indicated by the decreased number of trials completed and increased the probability of omissions. SER082 (1.0 mg/kg) blocked the effects of mCPP on performance. These data suggest that the overactivation of 5-HT2A receptors impairs response control in a 5-CSRT task, whereas the overactivation of 5-HT2C receptors can affect behavioral activity and/or arousal state of the animals for this food rewarded task.


Subject(s)
Amphetamines/pharmacology , Ketanserin/pharmacology , Reaction Time/drug effects , Receptors, Serotonin/drug effects , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Male , Piperazines/pharmacology , Rats , Rats, Wistar , Reaction Time/physiology , Receptor, Serotonin, 5-HT2A , Receptor, Serotonin, 5-HT2C , Receptors, Serotonin/physiology , Serial Learning/drug effects , Serial Learning/physiology
2.
Neuroscience ; 83(2): 489-99, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9460757

ABSTRACT

The purpose of the present study was to investigate whether differences in the function of monoaminergic systems could account for the variability in attention and impulsive behaviour between rats tested in the five-choice serial reaction time task in a model of attention deficit hyperactivity disorder. The ability of a rat to sustain its attention in this task can be assessed by measuring choice accuracy (percent correct responses) to visual stimuli, whereas the percentage of premature responses indicates the level of impulsivity. Following training with the five-choice serial reaction time task, rats were decapitated and brain pieces taken for neurochemical determination. Levels of dopamine, noradrenaline, 5-hydroxytryptamine, the dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid and the 5-hydroxytryptamine metabolite, 5-hydroxyindoleacetic acid were determined in the frontal cortex, nucleus accumbens, dorsal striatum and hippocampus. Multivariate regression analysis with a stepwise method revealed that the indeces of utilization of serotonin (5-hydroxyindoleacetic acid/5-hydroxytryptamine) in the left frontal cortex and dopamine (3,4-dihydroxyphenylacetic acid/dopamine) in the right frontal cortex together accounted for 49% of the variability in attentional performance between subjects. According to the regression analysis, a negative correlation existed between the left frontal cortex 5-hydroxyindoleacetic acid/5-hydroxytryptamine and choice accuracy, and a positive correlation was observed between 3,4-dihydroxyphenylacetic acid/dopamine ratio and choice accuracy on the opposite hemisphere. Additionally, right frontal cortex serotonin utilization was found to correlate positively with the proportion of premature hole responses and this relation accounted for about 24% of the variability in this index of impulsivity between animals. These data indicate that frontal cortex dopamine and serotonin play an important role in the modulation of attention and response control.


Subject(s)
Attention/physiology , Dopamine/metabolism , Impulsive Behavior/metabolism , Prefrontal Cortex/metabolism , Serotonin/metabolism , Animals , Brain Chemistry/physiology , Functional Laterality/physiology , Homovanillic Acid/metabolism , Hydroxyindoleacetic Acid/metabolism , Male , Norepinephrine/metabolism , Rats , Rats, Wistar , Reaction Time/physiology
3.
Eur Neuropsychopharmacol ; 8(1): 17-26, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9452936

ABSTRACT

The present experiments were designed to examine the effects of alpha-1 adrenergic stimulation and inhibition on memory encoding and to investigate whether the alpha-1 adrenergic and muscarinic cholinergic systems interact in the regulation of spatial navigation behavior in the Morris water maze test and we also studied the effects of D-cycloserine, a partial agonist at the glycine binding site on the N-methyl-D-aspartate (NMDA) receptor complex, on the performance of scopolamine-treated rats in this task. Pre-training subcutaneous administration of St-587 (a putative alpha-1 agonist) at 1000 micrograms kg-1 or 1500 micrograms kg-1 improved water maze navigation to a hidden platform. Prazosin (an alpha-1 antagonist), 300-2000 micrograms kg-1, did not significantly impair the spatial navigation performance. Pre-training administration of prazosin 1000 micrograms kg-1, but not 300 micrograms kg-1, slightly potentiated the deficit in water maze navigation seen after scopolamine (200 micrograms kg-1, pre-training intraperitoneal injection). Pre-training administration of St-587 at a dose 1500 micrograms kg-1, but not 500 micrograms kg-1, slightly ameliorated the scopolamine-induced (200 micrograms kg-1) impairment in performance of rats. Pre-training administration of prazosin at doses 300 or 1000 micrograms kg-1 or St-587 at doses 500 micrograms kg-1 or 1500 micrograms kg-1 did not have any significant influence on the scopolamine-induced (200 micrograms kg-1) increase of swimming speed. Furthermore, D-cycloserine at the dose of 300 micrograms kg-1 but not 1000 or 3000 micrograms kg-1 reversed the scopolamine (200 micrograms kg-1)-induced deficit in acquisition of the water maze task but not the increase in motor output (increased swimming speed). These results indicate that the stimulation of alpha-1 adrenoceptors may facilitate the encoding of new information. These findings suggest that alpha-1 adrenergic mechanisms do not participate or at least are not the most critical part of the noradrenergic system in the interaction between noradrenaline and muscarinic receptors in the modulation of learning and memory. In addition, these results suggest that D-cycloserine may be effective in alleviating states of central cholinergic hypofunction.


Subject(s)
Adrenergic alpha-1 Receptor Agonists , Adrenergic alpha-Agonists/pharmacology , Maze Learning/drug effects , Adrenergic alpha-Antagonists/pharmacology , Animals , Antimetabolites/pharmacology , Clonidine/analogs & derivatives , Clonidine/pharmacology , Cycloserine/pharmacology , Male , Muscarinic Antagonists/pharmacology , Prazosin/pharmacology , Rats , Rats, Wistar , Receptors, Glycine/agonists , Receptors, N-Methyl-D-Aspartate/agonists , Scopolamine/pharmacology , Swimming
4.
Eur Neuropsychopharmacol ; 7(2): 99-108, 1997 May.
Article in English | MEDLINE | ID: mdl-9169297

ABSTRACT

The effects of three different serotonin (5-HT) receptor antagonists (ketanserin, methysegide, methiothepin) in the modulation of attention, working memory and behavioural activity were investigated in this study by assessing the performance of rats in two separate cognitive models; the 5-choice serial reaction time (5-CSRT) task, which measures attention, and the delayed non-matching to position (DNMTP) task, which measures working memory. Methysergide and methiothepin bind at the 5-HT1 and 5-HT2 as well as the 5-HT5-7 receptors, with varying degrees of selectivity, and ketanserin binds at the 5-HT2A receptors rather selectively. None of these agents bind to any significant extent to 5-HT3 or 5-HT4 receptors. In the 5-CSRT task, neither methiothepin (0.15 mg/kg) nor ketanserin (1.0 and 3.0 mg/kg) impaired the choice accuracy of rats, although they induced sedation. The low doses of methysergide (1.5 and 3.0 mg/kg) slightly increased the behavioural activity of rats, whereas the high dose of methysergide (15.0 mg/kg) reduced behavioural activity and slightly reduced choice accuracy of the rats in the attentional task (monitoring of visual stimuli) under the baseline conditions or curtailed stimulus duration. This effect was not augmented at the reduced stimulus intensity. These findings suggest that the high dose of methysergide did not interfere with the visual discrimination of rats. Furthermore, methysergide did not reduce motivation for this task, since it did not increase food collection latencies. In the DNMTP task, methiothepin (0.15 mg/kg) induced a delay non-dependent deficit in choice accuracy. This could be due to an impaired alternation ability or akinesia, which increases an actual delay between sample and choice. Methiothepin (0.15 mg/kg) also interfered with behavioural activity of rats. Interestingly, ketanserin (1.0 mg/kg and 3.0 mg/kg) and methysergide (3.0-15.0 mg/kg) neither impaired the choice accuracy nor reduced the behavioural activity of rats in the DNMTP task. These results suggest that the blockade of 5-HT2A receptors does not interfere with attention and working memory per se. However, all three serotonin receptor antagonists interfered with behavioural activity of rats in the 5-CSRT task more severely than in the DNMTP task. The possible role of serotonin and non-serotonin receptors underlying the influence of these antagonists on behavioural activity will be discussed.


Subject(s)
Attention/drug effects , Ketanserin/pharmacology , Memory/drug effects , Methysergide/pharmacology , Serotonin Antagonists/pharmacology , Animals , Dose-Response Relationship, Drug , Male , Rats , Rats, Wistar , Task Performance and Analysis
5.
Psychopharmacology (Berl) ; 130(4): 303-12, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9160845

ABSTRACT

The role of serotonin (5-HT) and its interaction with the muscarinic or nicotinic receptor-mediated mechanisms in the modulation of working memory and motor activity was investigated by assessing the effects of 5-HT lesion and cholinergic receptor blockade on the performance of rats in a working memory (delayed non-matching to position, DNMTP) task. A global serotonergic lesion was induced by the intracerebroventricular administration of 5,7-dihydroxytryptamine (5,7-DHT). Post-mortem neurochemical analysis revealed that serotonin and 5-hydroxyindoleacetic acid (5-HIAA) levels were reduced in frontal and parieto-occipital cortices and in hippocampi of 5,7-DHT lesioned rats. 5-HIAA levels were also reduced in striatum. 5,7-DHT lesion slightly impaired choice accuracy of rats in the DNMTP task and also transiently reduced motor activity in rats. Even the lower dose of scopolamine (0.075 mg/kg), a muscarinic receptor antagonist, impaired the choice accuracy already at the shortest delay (i.e. not indicative of a working memory impairment per se), and caused a marked disruption of motor activity (lengthened response latencies, increased probability of omissions and decreased trials completed). Furthermore, the quaternary analogue, N-methylscopolamine (0.150 mg/kg), affected the motor activity of rats to the same extent as scopolamine. Mecamylamine (1.0; 3.0 mg/kg) also interfered with motor activity and it slightly decreased the choice accuracy, which was not dependent on the delay. Although mecamylamine disrupted the performance of rats in the DNMTP task, the disruption was not as severe as that seen with scopolamine. Moreover, both scopolamine and mecamylamine augmented the slight impairment on the choice accuracy of 5,7-DHT lesioned rats, but this was non-mnemonic in character. We conclude that there is no evidence for any major interaction between the serotonergic system and muscarinic or nicotinic cholinergic mechanisms in working memory per se, but muscarinic and nicotinic receptor antagonists may act additively with the 5,7-DHT lesion to disrupt the choice accuracy of rats.


Subject(s)
Brain/drug effects , Mecamylamine/pharmacology , Memory/drug effects , Muscarinic Antagonists/pharmacology , Nicotinic Antagonists/pharmacology , Scopolamine/pharmacology , Serotonin/physiology , 5,7-Dihydroxytryptamine/pharmacology , Animals , Brain/physiology , Hexamethonium/pharmacology , Male , Memory/physiology , Rats , Rats, Wistar
6.
Pharmacol Biochem Behav ; 56(4): 705-12, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9130297

ABSTRACT

This study investigated the role of alpha-1 adrenergic receptors in the modulation of attention and behavioral activity by assessing the effects of alpha-1 adrenergic receptor stimulation or blockade on the performance of rats in tasks involving vigilance (sustained attention) and selective attention [five-choice serial reaction time (5-CSRT)]. Pretesting subcutaneous administration of St-587 (a putative alpha-1 agonist) at 100 micrograms/kg, but not at 300 or 1000 micrograms/kg, significantly improved the choice accuracy of rats in the 5-CSRT task (monitoring of visual stimuli), whereas prazosin (a prototype alpha-1 antagonist) at 300 micrograms/kg administered subcutaneously slightly impaired choice accuracy of the rats in this task. Prazosin at 100 micrograms/kg blocked the ability of St-587 at 100 micrograms/kg to improve choice accuracy. Furthermore, St-587 at 100 micrograms/kg significantly increased the number of trials completed and reduced the probability of premature responses, whereas prazosin at 300 micrograms/kg decreased the number of trials completed and the latency of animals to make correct responses in the task. Prazosin at 100 micrograms/kg blocked the effect of St-587 at 100 micrograms/kg in increasing the number of trials completed. However, prazosin at 100 micrograms/kg did not abolish the effect of St-587 in reducing the probability of premature responses. Because the effect of St-587 at 100 micrograms/kg in improving choice accuracy is rather modest, it is possible that when the 100- and 300-microgram/kg doses of St-587 were administered in a counterbalanced order, this effect could have been overlooked due to day-to-day variation. Thus, the present results suggest that stimulation of alpha-1 adrenergic receptors can facilitate vigilance.


Subject(s)
Attention/physiology , Behavior, Animal/physiology , Receptors, Adrenergic, alpha-1/physiology , Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Attention/drug effects , Behavior, Animal/drug effects , Clonidine/analogs & derivatives , Clonidine/pharmacology , Male , Prazosin/pharmacology , Rats , Rats, Wistar , Reaction Time/drug effects
7.
J Psychopharmacol ; 11(1): 45-51, 1997.
Article in English | MEDLINE | ID: mdl-9097893

ABSTRACT

The present study investigated the role of alpha1 adrenergic receptors in the modulation of working memory and behavioural activity by assessing the effects of alpha1 adrenergic receptor stimulation or blockade on the performance of rats in a delayed non-matching to position task. St-587 (a putative agonist of alpha1 adrenoceptors) at a dose of 100 microg/kg slightly increased choice accuracy (per cent correct responses) of rats, but the effect was delay-independent which is interpreted as an improvement in choice accuracy and non-mnemonic (non-working memory) in character. Neither St-587 (300 or 1000 microg/kg) nor prazosin (a prototype antagonist of alpha1 adrenoceptors) (100 or 300 microg/kg) significantly affected the choice accuracy of rats in this task. Prazosin 300 microg/kg lengthened the latency for correct responses in the working memory task but did not affect food collection latencies. This combination of effects may reflect decreased motor output. St-587 300 and 1000 microg/kg, but not prazosin, increased food collection latencies in the working memory task. Thus, the present results suggest that alpha1 adrenergic receptors do not play any important role in spatial working memory as assessed using the delayed non-matching to position task, but that modulation of alpha1 adrenoceptors may affect motor activity and motivation in rats.


Subject(s)
Behavior, Animal/drug effects , Memory/drug effects , Receptors, Adrenergic, alpha-1/physiology , Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Clonidine/analogs & derivatives , Clonidine/pharmacology , Male , Prazosin/pharmacology , Rats , Rats, Wistar , Reaction Time/drug effects , Receptors, Adrenergic, alpha-1/drug effects
8.
Brain Res Bull ; 43(2): 163-71, 1997.
Article in English | MEDLINE | ID: mdl-9222529

ABSTRACT

A five-choice serial reaction time (5-CSRT) task was used to assess attention in rats. In this behavioral paradigm, the rats are required to spatially discriminate a short visual stimulus that will occur randomly in one of five locations while maintaining a sufficient activity level. The ability of a rat to maintain attention on the task can be measured by counting the choice accuracy (percent correct responses), whereas the probability of premature responses indicates the level of impulsivity. According to previous results [24], rats performing poorly in the task have a lower choice accuracy and make more premature responses than normally behaving individuals, i.e., a clear, inverse correlation was observed between choice accuracy and impulsiveness of rats. Methylphenidate, a psychostimulant that has been shown to alleviate the symptoms in attention deficit-hyperactivity disorder (ADHD), improved the choice accuracy of poor performing rats in this task [24]. The present results show that the correlation between choice accuracy and impulsivity exists also when the rats are tested using a reduced stimulus intensity or curtailed stimulus duration. The results of a pharmacological experiment suggested that atipamezole (30, 300, or 1000 micrograms/kg), a potent and specific alpha-2 antagonist that is known to increase the activity of monoaminergic systems in the brain, did not affect the percent correct responses in poor performers or in controls tested either at the baseline conditions or at a curtailed stimulus duration (which impaired their choice accuracy). At the doses of 300 and 1000 micrograms/kg, however, atipamezole slightly increased the probability of premature responses in all group of rats. The results of an electrophysiological study indicated that the poor choice accuracy or impulsiveness of rats is not related to the amount of cortically recorded spike-wave discharges/high voltage spindle (HVS) activity, which reflect thalamo-cortical oscillation. Atipamezole dose-dependently reduced the incidence and duration of HVSs. The present data, therefore, indicate that (a) alpha-2 antagonist treatment is not superior to methylphenidate treatment when investigated using acute administrations of the agents in poor performers of the 5-CSRT task, and (b) thalamic oscillations are not the reason for the attention deficit of rats in this model of ADHD. The relationship between choice accuracy and impulsivity is discussed.


Subject(s)
Adrenergic alpha-Antagonists/pharmacology , Attention/drug effects , Imidazoles/pharmacology , Thalamus/drug effects , Animals , Male , Rats , Rats, Wistar , Task Performance and Analysis
9.
Behav Pharmacol ; 8(5): 465-70, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9832985

ABSTRACT

The present study investigated whether an alpha 2-adrenoceptor antagonist (atipamezole) can influence hyperactivity induced by the systemic administration of scopolamine. In the water maze (WM) task, scopolamine (scop) 0.25 mg/kg treatment significantly increased swimming speed during the acquisition phase of this task. Atipamezole (ati) 30 micrograms/kg slightly reduced swimming speed both in saline- and in scop-treated rats. Ati 300 micrograms/kg slightly reduced swimming speed in saline-treated rats, and it prevented the scop-induced increase in swimming speed, because ati300-scop treated rats swam more slowly than the saline-saline group. In addition, ati 300 micrograms/kg reduced the total distance swum in scop-treated rats during a free swim trial (the platform was removed from the pool) performed 1 day after the acquisition phase of the WM test, even though it did not affect this parameter when administered alone. In the open arena task, which assessed the ambulation of rats when the pool was covered with a solid floor, scopolamine dose-dependently increased locomotor activity. The rats ambulated more when treated with scop 0.50 mg/kg compared to vehicle treatment, whereas the effect of scop 0.25 mg/kg treatment did not reach significance. In a test investigating the effects of ati 300 micrograms/kg and scop 0.50 mg/kg given singly or combined, the rats ambulated more during both ati 300 micrograms/kg and scop 0.50 mg/kg treatments given alone, but when combined, the rats ambulated less than during scop-saline treatment even though this was more than during control (saline-saline) treatment. These results indicate that the systemic administration of an alpha 2-antagonist can reduce hyperactivity induced by scopolamine.


Subject(s)
Adrenergic alpha-2 Receptor Antagonists , Adrenergic alpha-Antagonists/therapeutic use , Hyperkinesis/prevention & control , Imidazoles/therapeutic use , Adrenergic alpha-Antagonists/administration & dosage , Adrenergic alpha-Antagonists/pharmacology , Animals , Hyperkinesis/chemically induced , Imidazoles/administration & dosage , Imidazoles/pharmacology , Male , Maze Learning/drug effects , Maze Learning/physiology , Rats , Rats, Wistar , Receptors, Adrenergic, alpha-2/metabolism , Scopolamine , Swimming
10.
Pharmacol Biochem Behav ; 55(1): 107-15, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8870045

ABSTRACT

The present experiments were designed to investigate whether the alpha-1 adrenergic and muscarinic cholinergic systems interact in the regulation of spatial navigation behavior in the Morris water maze test and passive avoidance performance. Pretraining administration of scopolamine, a muscarinic antagonist, markedly impaired the acquisition of water maze task (a hidden platform version) as well as retention of this task. The drug also impaired slightly navigation to a visible platform. Pretraining subcutaneous administration of St-587 (alpha-1 agonist) at 2000 micrograms/kg slightly improved the water maze navigation to a hidden platform in control rats, but its effect was not augmented in scopolamine-treated rats. Pretraining administration of prazosin (alpha-1 antagonist) 1000 micrograms/kg or 2000 micrograms/kg did not significantly potentiate the scopolamine (muscarinic cholinergic antagonist)-induced (doses 200 micrograms/kg and 100 micrograms/kg, pretraining intraperitoneal injection) deficit in water maze navigation. Pretraining administration of prazosin at doses 1000 micrograms/kg and 2000 micrograms/kg or St-587 at doses 1000 micrograms/kg and 2000 micrograms/kg did not have any significant influence on scopolamine-induced (200 micrograms/kg or 400 micrograms/kg) disruption in passive avoidance performance. These findings suggest that alpha-1 adrenergic mechanisms do not participate or are not the most important component of the noradrenergic system in the interaction between noradrenaline and muscarinic receptors in the modulation of learning and memory. The analysis of results indicates that activation of alpha-1 adrenoceptors might facilitate the acquisition of water maze task in its initial phase, for instance, switching from wall hugging strategy to an active exploration strategy. Furthermore, the present data suggest that muscarinic cholinergic blockade may affect both mnemonic and nonmnemonic processes in rats.


Subject(s)
Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Avoidance Learning/drug effects , Clonidine/analogs & derivatives , Muscarinic Antagonists/pharmacology , Prazosin/pharmacology , Scopolamine/pharmacology , Animals , Clonidine/pharmacology , Male , Maze Learning/drug effects , Memory/drug effects , Rats , Rats, Wistar
11.
Neurobiol Learn Mem ; 66(2): 198-211, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8946412

ABSTRACT

Childhood hyperactivity (attention deficit hyperactivity disorder, ADHD) is a common behavior disorder among grade-school children. The characteristic symptoms are attentional problems and hyperkinesia. A number of animal models for ADHD syndrome have been developed, but very few of these models are truly representative in that they rarely describe both hyperactivity and attentional problems. Frequently the disorder has been induced in animals by pharmacological manipulations or exogenous brain lesions which are distinct from the disturbances in normal developmental processes which ultimately lead to ADHD. The main purpose of the present research was to develop a new animal model of ADHD, such that it would include an attention deficit, hyperactivity and alleviation by treatment with a psychostimulant. We used rats trained for a 5-choice serial reaction time task which assessed sustained attention. In this behavioral paradigm, rats are required to discriminate spatially a short visual stimulus that will occur randomly in one of five locations and have to maintain an adequate activity level. The ability of a rat to maintain its attention on the task can be measured by counting choice accuracy (percent correct responses), whereas percentage of premature responses indicates the level of motoric activity. According to the present results, rats performing poorly in the task have poorer choice accuracy and they make more premature responses than well performing individuals, i.e., a clear correlation was observed between these parameters (r = -0.59, p < .001). Interestingly, choice accuracy of poorly performing rats was found to be better at the beginning of testing, but it became impaired toward the end of testing session. It was also found that the deficiency was not due to impaired visual discrimination, since a reduction in the intensity of the visual stimulus impaired to a similar extent the performance of normal and poorly performing subjects. Equally, no relationship was observed between choice accuracy and the latencies to collect earned food pellets after the correct responses, indicating that motivational factors do not underlie the attention deficit or excessive activity of poorly performers. Furthermore, methylphenidate hydrochloride at doses of 100 and 1000 micrograms/kg slightly improved the attentional performance of poorly performing animals. At the dose 100 micrograms/kg, methylphenidate slightly decreased the probability of premature responses (impulsivity) in these rats, but 1000 micrograms/kg methylphenidate increased the impulsivity of both normal and poorly performing rats. However, methylphenidate did not affect the choice accuracy of normal animals tested at the baseline conditions or with the reduced stimulus duration which impaired their performance. The present data indicate that rats showing poor performance when trained and tested in a 5-choice serial reaction time task may be a model for ADHD.


Subject(s)
Attention Deficit Disorder with Hyperactivity/psychology , Behavior, Animal/drug effects , Disease Models, Animal , Methylphenidate/pharmacology , Animals , Male , Rats , Rats, Wistar
12.
J Neural Transm (Vienna) ; 103(5): 619-26, 1996.
Article in English | MEDLINE | ID: mdl-8811506

ABSTRACT

When compared to young Fisher 344 rats, aged Fisher 344 rats were impaired in their acquisition of the water maze task as indicated by longer escape latencies and distances to find a hidden platform. In a free swim trial which was performed after the training period, young rats had a better spatial bias, since they spent more time swimming in the previous training quadrant. Tacrine 3 mg/kg, an anticholinesterase, and selegiline 0.25 mg/kg, a MAO-B inhibitor, partially reversed the acquisition deficit in aged rats when administered on their own, and drug-treated aged rats swam more in the previous training quadrant than vehicle-treated aged rats during the free swim trial. Aged rats also swam slower than young rats. Tacrine, but not selegiline, increased swimming speed in aged rats. Taken as a whole, these data support the proposal that tacrine may be effective at alleviating age-related learning impairment and confirm the role of cholinergic dysfunction in the spatial learning deficit in aged rats.


Subject(s)
Aging/psychology , Cholinesterase Inhibitors/pharmacology , Maze Learning/drug effects , Monoamine Oxidase Inhibitors/pharmacology , Selegiline/pharmacology , Tacrine/pharmacology , Animals , Drug Evaluation, Preclinical , Escape Reaction/drug effects , Male , Rats , Rats, Inbred F344 , Reaction Time/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...